Skip to main content
  1. Right Decisions
  2. DGRefHelp - NHS Dumfries & Galloway
  3. Sexual health
  4. Contraception
  5. Back
  6. Copper Intrauterine Device Cu-IUD
  7. Insertion. advice and aftercare following insertion

Insertion. advice and aftercare following insertion

Warning

Insertion

1. Discussion

This is essential to ensure individuals make an informed choice about their contraception options and can give informed consent. These may be undertaken face-to-face, via telephone or virtual appointment, or by self-assessment and signposting to patient resources. Women can be encouraged to watch an eight minute information film produced by Lothian Sexual Health available at https://www.lothiansexualhealth.scot/contraception/iud-ius/

2. When can a Cu-IUD be inserted

A Cu-IUD can be inserted at any time during the menstrual cycle providing that pregnancy can be reasonably excluded (see Box 1). Recommendations for starting or switching to a Cu-IUD can be found in Table 2 and Table 3.

The Cu-IUD can be used for EC if inserted within 5 days of the first episode of UPSI that cycle, or within 5 days of the earliest expected date of ovulation (see emergency contraception protocol)

Contraception After Pregnancy | CoSRH

 

 

 

Table 2: Starting Cu-IUD (no recent hormonal contraception) [from CoSRH Clinical Guideline: Intrauterine contraception (March 2023)]

 

Current Situation

 

Timing of insertion of LNG-IUD

Additional Precautions required

No recent hormonal contraception and no recent pregnancy

 

Any time in a natural menstrual cycle if reasonably certain the individual is not pregnant* or at risk of pregnancy (unless qualifies for pregnancy use as EC)

No

Cu-IUD within licensed duration of use

 

Any time

Ideally abstain/use condoms for 7 days prior to change in case new device cannot be inserted unless criteria for EC insertion are met

Cu-IUD past licensed duration of use

 

Any time in a natural menstrual if reasonably certain the individual is not pregnant* or at risk of pregnancy (unless qualifies for use as EC)

No

Post partum (vaginal birth or Caesarian section, breastfeeding or non-breast feeding)

Within 48 hours after childbirth or from 4 weeks after childbirth if it is reasonably certain the individual is not pregnant* or at risk of pregnancy (unless criteria for use as EC apply)

No

Following abortion of miscarriage

Post-surgical abortion or surgical management of miscarriage: ideally insert at the time of the procedure

 

Post-medical abortion or miscarriage: IUC can be inserted any time after expulsion of pregnancy

 

No

Following use of oral emergency contraception

Within the first 5 days (120 hours) following first UPSI in a natural menstrual cycle or within 5 days after the earliest estimated day of ovulation

No additional precautions required

 

If there has been UPSI in this natural menstrual cycle that occurred >5 days ago AND it is >5 days after the earliest estimated date of ovulation (or date of ovulation cannot be estimated), a Cu-IUD cannot be inserted until pregnancy can be excluded by a high-sensitivity pregnancy test taken ≥21 days after last UPSI

Condoms or bridging contraception until Cu-IUD can be inserted

UPSI (unprotected sexual intercourse)

*See Box 1 for how to exclude pregnancy.

Table 3: Switching to Cu-IUD from a hormonal contraceptive method

 

Current Situation

 

Timing of insertion

Additional Precautions required

CHC use

 

At any time if CHC has been used correctly (or criteria for use as EC are met)

No

POP (traditional, desogestrel or

drospirenone

 

 

At any time if POP has been used correctly (or criteria for use as EC are met)

No

 

ENG implant within 3 years after insertion

 

Any time

No

 

ENG implant in situ for

3-4 years

Any time if PT negative

No

Repeat PT 21days after last UPSI

 

ENG implant in situ for >4 years and no UPSI in the last 21 days

Any time if PT negative

No

ENG implant in situ for >4 years and UPSI in the last 21 days

If PT negative AND all UPSI that has taken place in the last 21 days was within the last 5 days, Cu-IUD can be inserted as EC

No

Cu-IUD cannot be inserted if any UPSI occurred between 5 and 21 days ago

Consider PT and EC. Bridge with alternative contraception until pregnancy can be excluded by a high sensitivity PT taken ≥21 days after last UPSI

 

 

Table 3: Switching to Cu-IUD from a hormonal contraceptive method (contd)

 

 

Current Situation

 

Timing of insertion

Additional Precautions required

 

Progestogen-only injectable (DMPA) ≤14 weeks post-injection

 

 

Any time

No

 

Progestogen-only injectable (DMPA) >14 weeks post-injection and no UPSI since 14 weeks

 

Any time

No

 

Progestogen-only injectable (DMPA) >14 weeks post-injection

 AND

 UPSI since 14 weeks post-injection, all of which took place ≥21 days ago

 

Any time if PT negative

No

 

Progestogen-only injectable (DMPA) >14 weeks post-injection

 AND

 UPSI since 14 weeks post-injection, some of which took place within the last 21 day

 

If PT negative AND all UPSI that has taken place in the last 21 days was within the last 5 days, Cu-IUD can be inserted as EC

No

Cu-IUD cannot be inserted if any UPSI occurred between 5 and 21 days ago

Consider PT and EC. Bridge with alternative contraception until pregnancy can be excluded by a high-sensitivity PT taken ≥21 days after last UPSI

 

 

Table 3: Switching to Cu-IUD from a hormonal contraceptive method (contd)

 

 

Current Situation

 

Timing of insertion

Additional Precautions required

 

52 mg LNG-IUD in situ for < 8 years

OR

19.5 mg LNG-IUD in situ for < 5 yrs

OR

13.5 mg LNG-IUD in situ for < 3 yrs

Any time

No

Ideally abstain/use condoms for 7 days prior to change in case new device can’t be inserted

 

52 mg LNG-IUD in situ for >8 yrs

and

no UPSI within the last 21 days

 

OR

 

19.5 mg LNG-IUD in situ for >5 yrs and

 no UPSI within the last 21 days

 

 OR

 

13.5 mg LNG-IUD in situ for >3 yrs

and

 no UPSI within the last 21 days

 

Any time if PT negative on day of replacement

No

 

52 mg LNG-IUD in situ for >8 years† and UPSI within the last 21 days

OR

 19.5 mg LNG-IUD in situ for >5 years and UPSI within the last 21 days

OR

 13.5 mg LNG-IUD in situ for >3 years and UPSI within the last 21 days

 

If PT negative AND all UPSI that has taken place in the last 21 days was within the last 5 days, Cu-IUD can be inserted as EC

No

CHC, combined hormonal contraception; DMPA, depot medroxyprogesterone acetate; DRSP, drospirenone; ENG, etonogestrel; HFI, hormone-free interval; IUC, intrauterine contraception; LNG-IUD, levonorgestrel intrauterine device; POP, progestogen-only pill; PT, pregnancy test; UPSI, unprotected sexual intercourse. †Recommendations for the 52 mg LNG-IUD insertion relate to devices inserted before age 45 years.

Insertion checklist

 

Intrauterine contraception pre-insertion checklist for the minimum criteria that should be met prior to insertion.      

 

Safe Cu-IUD Insertion

Training: Clinicians offering Cu-IUD insertion should hold the COSRH Letter of Competence in Intrauterine Techniques. Immediate postpartum intrauterine contraception (PPIUC) technique is different to standard Cu-IUD insertion and should only be performed by those who have trained in this technique.

 

Assistants and Chaperones: A chaperone should be offered for all intimate examinations. The chaperone’s role is to support the patient.  An appropriately trained assistant should be present during all cervical instrumentation procedures. The assistant can also fill the role of a chaperone if trained. The assistant should support the individual during the Cu-IUD procedure and monitor the patient for any signs of pain or distress.

 

Check the device has not expired: If an expired device is inadvertently inserted, inform the individual of the error and offer the option of retaining the device or having it removed and replaced. The expiry date relates to the microbiological sterility of the device. Risk of infection from loss of microbiological sterility could well be lower than the risk of infection if the device is replaced again. Manage the error according to local clinical governance policies.

 

Pain associated with Cu-IUD insertion

Cu-IUD insertions can cause mild-to-moderate pain or discomfort. Analgesia options should be discussed, offered and documented. NSAIDs such as ibuprofen can reduce pain after Cu-IUD insertion.

 

Emergency management for problems at IUD insertion

 

Cu-IUD insertion can trigger a vasovagal response. Drugs and equipment required for

resuscitation must be available, accessible, clearly labelled, adequately maintained and their location known to all staff.  Follow locally agreed risk management policies for the treatment of emergencies.

 

Documentation

Clinicians inserting or removing Cu-IUDs should document the procedure and consultation in line with local policy and protocol and notify (where applicable and with consent) other relevant healthcare providers (e.g. primary care) of the type of device, date of insertion and recommended duration of use.

 

Advice and Aftercare following insertion

After Cu-IUD insertion, individuals should be given information on the device inserted, including the name of the device, its mode of action, duration of use and that it will become effective immediately. The manufacturer’s booklet/card will usually be given to the patient.

Where a Cu-IUD has been inserted outside of product licence information about how and when to perform a pregnancy test should be given.

With the exception of PPIUC, routine post-insertion check-ups with a clinician are not required. They should be advised to seek review at any time if they have concerns or cannot locate the coil threads. They should be given information on who to contact and how. Local pathways should be followed for PPIUC insertions and follow-up.

Cu-IUD users should feel for the threads within the first 4–6 weeks after insertion and then at regular intervals (e.g. monthly or after menses) and if they have any concerns suggestive of Cu-IUD displacement (e.g. change in bleeding pattern, new-onset pelvic pain).  Clinicians should explain how to feel for Cu-IUD threads and that users should seek review if threads are not palpable, thread length becomes shorter or longer, or the stem of the device is felt. The individual should be advised to abstain or use an alternative method of contraception until the Cu-IUD position is confirmed, and if there has been any recent, condomless sex they should seek advice as emergency contraception may be required.

 

Individuals should be advised to seek urgent review if they have:

  • Symptoms of pelvic infection (e.g. change in vaginal discharge, pelvic pain and intermenstrual/ postcoital bleeding)
  • Concerns regarding their bleeding pattern
  • A positive pregnancy test.

Women can be encouraged to watch a 4 minute video produced by The West of Scotland Managed Clinical Network for Sexual Health for women who have recently had a IUD inserted which gives advice on what to expect, how to check for threads and when to seek advice.

https://sexualhealthdg.co.uk/iuc.php

 

11. Advice about use of menstrual cups, discs and tampons

 

There could be increased risk of expulsion associated with menstrual cup use. Users should be advised to follow the manufacturer’s instructions. Care should be taken not to dislodge the Cu-IUD by accidently pulling the Cu-IUD threads when removing the menstrual device’

 

There are not robust studies to inform effect of use of tampons on risk of expulsion.

 

There is no clear evidence of increased risk of infection associated with use of tampons, menstrual cups/discs or intercourse in the days or weeks after Cu-IUD insertion.

 

 

 

12. Advice for individuals requiring magnetic resonance imaging

 

Individuals should inform their MRI department so that local guidelines can be followed. Cu-IUD inserted outside of the UK may contain different metals (eg Chinese ring contains steel) and might not be MRI safe. Advice should be sought from the local radiology department.

 

 

Editorial Information

Last reviewed: 31/08/2023

Next review date: 30/09/2025

Author(s): West of Scotland Managed Clinical Network in Sexual Health Clinical Guidelines Group .

Version: 10.1

Approved By: West of Scotland Managed Clinical Network in Sexual Health

Reviewer name(s): George Laird.